Monday, June 15, 2026

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

U.S. Defense Strategy Shift: What Does It Mean for Korea’s Security in 2026?

U.S. Deputy Secretary Colby's visit to South Korea signals a shift in defense strategy, focusing on China and altering military exercises.

Russia Gets $10B in Arms on a ‘Crazy’ Discount from North Korea

North Korea has provided military aid to Russia worth $10 billion, receiving only $718 million in return, highlighting unequal terms.

Tag: Toxins

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.